Indian Army Department Of Military Affairs Medicines Tender Pune Maharashtra 410301 - URSODEOXYCHOLIC ACID 150 MG, APIXABAN 5 MG & 2.5 MG, Febuxostat 40 MG 2026
Progress
Key Highlights
- • Product category includes a diverse set of pharmaceuticals and APIs for government procurement
- • Option clause enabling 25% quantity variation during and after contract; dynamic delivery planning
- • Delivery destination explicitly AICTS Pune; multiple deliveries permitted
- • Mandatory submission of PAN, GSTIN, cancelled cheque and EFT mandate for bid eligibility
- • Turnover criteria applicable to bidders and OEMs; exact thresholds to be taken from bid document
- • Scope includes SITC and operator training; statutory clearances if required
Tender Overview
The Indian Army, Department Of Military Affairs, invites bids for the supply of listed pharmaceutical products including URSODEOXYCHOLIC ACID 150 MG TAB, ASPIRIN 75 MG TAB, PREGABALIN 75 MG CAP PER TAB, FEBUXOSTAT 40 MG TAB, FEXOFENADINE HCL 180 MG TAB, APIXABAN 5 MG TAB, and APIXABAN 2.5 MG TAB, for delivery to AICTS Pune, Maharashtra. The scope covers supply, installation, testing and commissioning where applicable, plus operator training and any required statutory clearances. The bid allows up to a 25% quantity variation during contract execution. Estimated value and EMD amounts are not disclosed in the provided data. Unique delivery terms reference AICTS Pune as the destination.
Key Specifications
-
URSODEOXYCHOLIC ACID 150 MG TAB
-
ASPIRIN 75 MG TAB
-
PREGABALIN 75 MG CAP PER TAB
-
FEBUXOSTAT 40 MG TAB
-
FEXOFENADINE HCL 180 MG TAB
-
APIXABAN 5 MG TAB
-
APIXABAN 2.5 MG TAB
-
Delivery to AICTS Pune; SITC scope; operator training
Terms & Conditions
-
Up to 25% quantity variation during contract; adjust delivery as per extension rules
-
Delivery at AICTS Pune; installation and commissioning included where applicable
-
Mandatory financial and regulatory documents; GST, PAN, EFT mandate
Important Clauses
Payment Terms
Not specified in provided data; refer to bid document for advance/ milestone payments and timelines
Delivery Schedule
Delivery to AICTS Pune; additional time calculations based on increased quantity and original delivery period; minimum 30 days
Penalties/Liquidated Damages
Not specified in the provided data; check bid terms for LD rates or performance bonds
Bidder Eligibility
-
Demonstrated turnover in line with bid document (3-year average) for bidders and OEMs
-
Ability to supply and install SITC for listed pharmaceutical products
-
Compliance with GST, PAN, and EFT Mandate submission
Tender Data
Bid Details
Quantity
164500
Category
URSODEOXYCHOLIC ACID 150 MG TAB
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
RA Qualification Rule
H1-Highest Priced Bid Elimination
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
No
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Past Performance
50 %
Warranty Period
5 years
Experience Required
3 Year (s)
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
URSODEOXYCHOLIC ACID 150 MG TAB , ASPIRIN 75 MG TAB , PREGABALIN 75 MG CAP PER TAB , FEBUXOSTAT 40 MG TAB , FEXOFENADINE HCL 180 MG TAB , APIXABAN 5 MG TAB , APIXABAN 2 POINT 5 MG TAB
Advisory Bank
State Bank of India
ePBG Percentage
3%
ePBG Duration (Months)
2
Delivery Details
Max Delivery Days
30
Delivery Locations
1
Delivery Cities
PUNE CITY
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | PUNE CITY | PUNE CITY | - | - | 2000 | 30 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-10030893.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
7 Items Sign in to view GEM price trends Sign in for GEM prices
URSODEOXYCHOLIC ACID 150 MG TAB
URSODEOXYCHOLIC ACID 150 MG TAB
ASPIRIN 75 MG TAB
ASPIRIN 75 MG TAB
PREGABALIN 75 MG CAP PER TAB
PREGABALIN 75 MG CAP PER TAB
FEBUXOSTAT 40 MG TAB
FEBUXOSTAT 40 MG TAB
FEXOFENADINE HCL 180 MG TAB
FEXOFENADINE HCL 180 MG TAB
APIXABAN 5 MG TAB
APIXABAN 5 MG TAB
APIXABAN 2 POINT 5 MG TAB
APIXABAN 2 POINT 5 MG TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | URSODEOXYCHOLIC ACID 150 MG TAB | URSODEOXYCHOLIC ACID 150 MG TAB | 2,000 | no | aictsgemmedicine | 30 | |
| 2 | ASPIRIN 75 MG TAB | ASPIRIN 75 MG TAB | 81,000 | no | aictsgemmedicine | 30 | |
| 3 | PREGABALIN 75 MG CAP PER TAB | PREGABALIN 75 MG CAP PER TAB | 6,700 | no | aictsgemmedicine | 30 | |
| 4 | FEBUXOSTAT 40 MG TAB | FEBUXOSTAT 40 MG TAB | 3,100 | no | aictsgemmedicine | 30 | |
| 5 | FEXOFENADINE HCL 180 MG TAB | FEXOFENADINE HCL 180 MG TAB | 6,000 | no | aictsgemmedicine | 30 | |
| 6 | APIXABAN 5 MG TAB | APIXABAN 5 MG TAB | 27,400 | no | aictsgemmedicine | 30 | |
| 7 | APIXABAN 2 POINT 5 MG TAB | APIXABAN 2 POINT 5 MG TAB | 38,300 | no | aictsgemmedicine | 30 |
Categories
5
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
GST certificate
PAN card
Cancelled Cheque
EFT Mandate certified by Bank
Audited Balance Sheets or CA/Cost Accountant turnover certificate
OEM authorization (if applicable)
Technical bid documents and compliance certificates
Frequently Asked Questions
Key insights about MAHARASHTRA tender market
How to bid for the Indian Army medicines tender in Pune 2026?
Bidders must submit PAN, GSTIN, cancelled cheque, and EFT mandate; provide turnover evidence for last 3 financial years, and OEM turnover if applicable. Include technical bid, GST, and bank certifications; ensure SITC scope and operator training are detailed per bid.
What documents are required for the Pune AICTS pharmaceutical bid?
Required documents include PAN card, GSTIN, cancelled cheque, EFT mandate, audited financials or CA certificate for turnover, OEM authorization (if applicable), vendor code creation details, and technical bid with compliance certificates for listed medicines and APIs.
What is the delivery destination for this medicines tender in Maharashtra?
Delivery is to AICTS PUNE, Maharashtra 410301. The contract allows up to 25% quantity variation, with delivery period linked to the original order date and extended as per option clause; minimum additional time is 30 days.
What are the key product categories in this Pune tender 2026?
Key product categories include URSODEOXYCHOLIC ACID 150 MG tablets, ASPIRIN 75 MG tablets, PREGABALIN 75 MG capsules, FEBUXOSTAT 40 MG tablets, FEXOFENADINE HCL 180 MG tablets, APIXABAN 5 MG tablets, and APIXABAN 2.5 MG tablets.
Are installation and commissioning included in the scope of supply?
Yes, the scope explicitly covers Supply, Installation, Testing, and Commissioning (SITC) along with training of operators and any statutory clearances required, where applicable.
What turnover evidence is accepted for bidder eligibility?
Submit certified Audited Balance Sheets or a CA/Cost Accountant certificate indicating the last 3-year average turnover; if the bidder is recently formed, use completed years post-incorporation for turnover calculations per bid document.
Is there a penalty or LD clause for late delivery in this tender?
Specific LD details are not provided here; bidders should consult the bid document for liquidated damages or penalty terms, including rate per day and cap on LDs for delayed delivery.
What are the OEM turnover requirements for this procurement?
The OEM must meet minimum average annual turnover over the last 3 financial years as stated in the bid document; provide audited statements or CA certificate to prove turnover; if newer than 3 years, use turnover of completed years post-incorporation.